Annual EBITDA
-$5.65 M
+$15.41 M+73.19%
December 31, 2023
Summary
- As of February 8, 2025, FRTX annual EBITDA is -$5.65 million, with the most recent change of +$15.41 million (+73.19%) on December 31, 2023.
- During the last 3 years, FRTX annual EBITDA has risen by +$15.26 million (+72.98%).
- FRTX annual EBITDA is now -370.67% below its all-time high of -$1.20 million, reached on December 1, 1990.
Performance
FRTX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$1.23 M
-$3.34 M-158.06%
December 31, 2023
Summary
- As of February 8, 2025, FRTX quarterly EBITDA is -$1.23 million, with the most recent change of -$3.34 million (-158.06%) on December 31, 2023.
- Over the past year, FRTX quarterly EBITDA has dropped by -$3.34 million (-158.06%).
- FRTX quarterly EBITDA is now -107.23% below its all-time high of $16.98 million, reached on September 1, 2011.
Performance
FRTX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$5.65 M
+$3.29 M+36.79%
December 31, 2023
Summary
- As of February 8, 2025, FRTX TTM EBITDA is -$5.65 million, with the most recent change of +$3.29 million (+36.79%) on December 31, 2023.
- Over the past year, FRTX TTM EBITDA has increased by +$3.29 million (+36.79%).
- FRTX TTM EBITDA is now -256.98% below its all-time high of $3.60 million, reached on June 1, 2012.
Performance
FRTX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
FRTX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +73.2% | -158.1% | +36.8% |
| 3 y3 years | +73.0% | -158.1% | +36.8% |
| 5 y5 years | +71.0% | -158.1% | +36.8% |
FRTX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +85.7% | -158.1% | +86.9% | at high | +85.8% |
| 5 y | 5-year | at high | +85.7% | -158.1% | +90.7% | at high | +86.1% |
| alltime | all time | -370.7% | +85.7% | -107.2% | +90.7% | -257.0% | +86.1% |
Fresh Tracks Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$5.65 M(-73.2%) | -$1.23 M(-158.1%) | -$5.65 M(-36.8%) |
| Sep 2023 | - | $2.12 M(-193.1%) | -$8.94 M(-47.6%) |
| Jun 2023 | - | -$2.27 M(-46.7%) | -$17.06 M(+7.1%) |
| Mar 2023 | - | -$4.26 M(-5.6%) | -$15.93 M(-24.4%) |
| Dec 2022 | -$21.06 M(-46.5%) | -$4.51 M(-24.9%) | -$21.06 M(-6.8%) |
| Sep 2022 | - | -$6.01 M(+427.7%) | -$22.60 M(-24.2%) |
| Jun 2022 | - | -$1.14 M(-87.9%) | -$29.84 M(-25.1%) |
| Mar 2022 | - | -$9.40 M(+55.2%) | -$39.81 M(+1.1%) |
| Dec 2021 | -$39.38 M(+88.4%) | - | - |
| Dec 2021 | - | -$6.06 M(-54.3%) | -$39.38 M(-3.2%) |
| Sep 2021 | - | -$13.24 M(+19.2%) | -$40.69 M(+28.1%) |
| Jun 2021 | - | -$11.11 M(+23.9%) | -$31.77 M(+23.3%) |
| Mar 2021 | - | -$8.97 M(+21.8%) | -$25.77 M(+23.3%) |
| Dec 2020 | -$20.90 M(-3.9%) | -$7.36 M(+70.3%) | -$20.90 M(-13.9%) |
| Sep 2020 | - | -$4.32 M(-15.5%) | -$24.28 M(+2.7%) |
| Jun 2020 | - | -$5.12 M(+24.8%) | -$23.64 M(+9.9%) |
| Mar 2020 | - | -$4.10 M(-61.8%) | -$21.52 M(-1.1%) |
| Dec 2019 | -$21.75 M(+11.6%) | -$10.74 M(+192.3%) | -$21.76 M(+45.6%) |
| Sep 2019 | - | -$3.68 M(+22.7%) | -$14.95 M(-2.4%) |
| Jun 2019 | - | -$3.00 M(-31.1%) | -$15.32 M(-11.9%) |
| Mar 2019 | - | -$4.34 M(+10.4%) | -$17.40 M(-10.7%) |
| Dec 2018 | -$19.50 M(+54.8%) | -$3.94 M(-2.8%) | -$19.50 M(+0.6%) |
| Sep 2018 | - | -$4.05 M(-20.2%) | -$19.37 M(+5.8%) |
| Jun 2018 | - | -$5.07 M(-21.2%) | -$18.30 M(+11.7%) |
| Mar 2018 | - | -$6.44 M(+69.0%) | -$16.38 M(+30.1%) |
| Dec 2017 | -$12.59 M(+56.2%) | -$3.81 M(+27.6%) | -$12.59 M(+11.7%) |
| Sep 2017 | - | -$2.98 M(-5.3%) | -$11.28 M(+6.6%) |
| Jun 2017 | - | -$3.15 M(+19.1%) | -$10.58 M(+24.9%) |
| Mar 2017 | - | -$2.65 M(+6.1%) | -$8.47 M(+5.1%) |
| Dec 2016 | -$8.06 M(-2.2%) | -$2.49 M(+8.9%) | -$8.06 M(+4.5%) |
| Sep 2016 | - | -$2.29 M(+119.9%) | -$7.71 M(+41.1%) |
| Jun 2016 | - | -$1.04 M(-53.3%) | -$5.47 M(-21.0%) |
| Mar 2016 | - | -$2.23 M(+4.0%) | -$6.92 M(-16.0%) |
| Dec 2015 | -$8.24 M(-44.9%) | -$2.15 M(+4779.5%) | -$8.24 M(-21.1%) |
| Sep 2015 | - | -$44.00 K(-98.2%) | -$10.45 M(-27.5%) |
| Jun 2015 | - | -$2.50 M(-29.8%) | -$14.41 M(-7.1%) |
| Mar 2015 | - | -$3.56 M(-18.2%) | -$15.50 M(+3.6%) |
| Dec 2014 | -$14.96 M(-48.6%) | -$4.35 M(+8.6%) | -$14.96 M(+21.1%) |
| Sep 2014 | - | -$4.01 M(+11.5%) | -$12.35 M(-30.6%) |
| Jun 2014 | - | -$3.59 M(+19.1%) | -$17.79 M(-24.2%) |
| Mar 2014 | - | -$3.02 M(+73.3%) | -$23.47 M(-19.5%) |
| Dec 2013 | -$29.14 M(+38.1%) | -$1.74 M(-81.6%) | -$29.14 M(-15.1%) |
| Sep 2013 | - | -$9.45 M(+1.9%) | -$34.34 M(+7.4%) |
| Jun 2013 | - | -$9.27 M(+6.7%) | -$31.96 M(+6.0%) |
| Mar 2013 | - | -$8.69 M(+25.2%) | -$30.14 M(+42.8%) |
| Dec 2012 | -$21.11 M(+297.1%) | -$6.94 M(-1.9%) | -$21.11 M(+3.2%) |
| Sep 2012 | - | -$7.07 M(-5.1%) | -$20.45 M(-668.4%) |
| Jun 2012 | - | -$7.45 M(-2210.2%) | $3.60 M(+13.3%) |
| Mar 2012 | - | $353.00 K(-105.6%) | $3.18 M(-159.8%) |
| Dec 2011 | -$5.32 M(-81.3%) | -$6.29 M(-137.0%) | -$5.32 M(-5.1%) |
| Sep 2011 | - | $16.98 M(-315.7%) | -$5.60 M(-80.5%) |
| Jun 2011 | - | -$7.87 M(-3.3%) | -$28.68 M(+0.2%) |
| Mar 2011 | - | -$8.14 M(+23.9%) | -$28.61 M(+0.7%) |
| Dec 2010 | -$28.41 M(+9.6%) | -$6.57 M(+7.6%) | -$28.41 M(-0.6%) |
| Sep 2010 | - | -$6.10 M(-21.8%) | -$28.58 M(-1.0%) |
| Jun 2010 | - | -$7.80 M(-1.6%) | -$28.88 M(+10.1%) |
| Mar 2010 | - | -$7.93 M(+17.6%) | -$26.24 M(+1.2%) |
| Dec 2009 | -$25.93 M(-24.8%) | -$6.74 M(+5.4%) | -$25.93 M(-2.6%) |
| Sep 2009 | - | -$6.40 M(+24.0%) | -$26.63 M(-10.4%) |
| Jun 2009 | - | -$5.16 M(-32.3%) | -$29.73 M(-9.2%) |
| Mar 2009 | - | -$7.62 M(+2.3%) | -$32.74 M(-5.0%) |
| Dec 2008 | -$34.48 M(-6.8%) | -$7.45 M(-21.5%) | -$34.48 M(-4.5%) |
| Sep 2008 | - | -$9.49 M(+16.0%) | -$36.09 M(+0.0%) |
| Jun 2008 | - | -$8.18 M(-12.6%) | -$36.08 M(-0.8%) |
| Mar 2008 | - | -$9.35 M(+3.1%) | -$36.39 M(-1.6%) |
| Dec 2007 | -$37.00 M | -$9.07 M(-4.3%) | -$37.00 M(+1.6%) |
| Sep 2007 | - | -$9.48 M(+11.7%) | -$36.41 M(+5.8%) |
| Jun 2007 | - | -$8.49 M(-14.8%) | -$34.40 M(+19.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2007 | - | -$9.96 M(+17.5%) | -$28.91 M(+25.0%) |
| Dec 2006 | -$23.13 M(+4.9%) | -$8.48 M(+13.5%) | -$23.13 M(+15.7%) |
| Sep 2006 | - | -$7.47 M(+149.0%) | -$19.99 M(+10.6%) |
| Jun 2006 | - | -$3.00 M(-28.3%) | -$18.07 M(-6.6%) |
| Mar 2006 | - | -$4.18 M(-21.6%) | -$19.34 M(-12.3%) |
| Dec 2005 | -$22.06 M(+2.6%) | -$5.34 M(-3.8%) | -$22.06 M(+7.3%) |
| Sep 2005 | - | -$5.55 M(+29.9%) | -$20.56 M(+3.3%) |
| Jun 2005 | - | -$4.27 M(-38.1%) | -$19.90 M(-1.0%) |
| Mar 2005 | - | -$6.90 M(+79.6%) | -$20.11 M(-6.5%) |
| Dec 2004 | -$21.51 M(-4.7%) | -$3.84 M(-21.3%) | -$21.51 M(-10.1%) |
| Sep 2004 | - | -$4.88 M(+9.1%) | -$23.91 M(+9.0%) |
| Jun 2004 | - | -$4.48 M(-46.0%) | -$21.95 M(-9.1%) |
| Mar 2004 | - | -$8.30 M(+32.8%) | -$24.14 M(+7.0%) |
| Dec 2003 | -$22.56 M(-21.9%) | -$6.25 M(+114.1%) | -$22.56 M(-5.4%) |
| Sep 2003 | - | -$2.92 M(-56.2%) | -$23.85 M(-24.1%) |
| Jun 2003 | - | -$6.67 M(-0.8%) | -$31.41 M(+4.4%) |
| Mar 2003 | - | -$6.72 M(-10.9%) | -$30.08 M(+4.1%) |
| Dec 2002 | -$28.89 M(+88.3%) | -$7.54 M(-28.0%) | -$28.89 M(+22.9%) |
| Sep 2002 | - | -$10.48 M(+96.2%) | -$23.51 M(+37.8%) |
| Jun 2002 | - | -$5.34 M(-3.5%) | -$17.06 M(+2.1%) |
| Mar 2002 | - | -$5.53 M(+156.5%) | -$16.70 M(+8.8%) |
| Dec 2001 | -$15.35 M(+2.6%) | -$2.16 M(-46.5%) | -$15.35 M(-11.4%) |
| Sep 2001 | - | -$4.03 M(-19.0%) | -$17.31 M(+1.1%) |
| Jun 2001 | - | -$4.98 M(+19.3%) | -$17.13 M(+14.8%) |
| Mar 2001 | - | -$4.17 M(+1.3%) | -$14.93 M(-1.4%) |
| Dec 2000 | -$14.96 M(+87.0%) | -$4.12 M(+7.0%) | -$15.14 M(+31.9%) |
| Sep 2000 | - | -$3.85 M(+38.8%) | -$11.48 M(+7.3%) |
| Jun 2000 | - | -$2.78 M(-36.8%) | -$10.70 M(-4.2%) |
| Mar 2000 | - | -$4.39 M(+849.2%) | -$11.17 M(+41.8%) |
| Dec 1999 | -$8.00 M(-10.1%) | -$462.50 K(-84.9%) | -$7.88 M(-20.5%) |
| Sep 1999 | - | -$3.07 M(-5.4%) | -$9.92 M(+9.6%) |
| Jun 1999 | - | -$3.25 M(+195.1%) | -$9.05 M(+0.5%) |
| Mar 1999 | - | -$1.10 M(-56.0%) | -$9.00 M(-1.1%) |
| Dec 1998 | -$8.90 M(+29.0%) | -$2.50 M(+13.6%) | -$9.10 M(+12.3%) |
| Sep 1998 | - | -$2.20 M(-31.3%) | -$8.10 M(+28.6%) |
| Jun 1998 | - | -$3.20 M(+166.7%) | -$6.30 M(+10.5%) |
| Mar 1998 | - | -$1.20 M(-20.0%) | -$5.70 M(-17.4%) |
| Dec 1997 | -$6.90 M(-4.2%) | -$1.50 M(+275.0%) | -$6.90 M(-5.5%) |
| Sep 1997 | - | -$400.00 K(-84.6%) | -$7.30 M(-24.0%) |
| Jun 1997 | - | -$2.60 M(+8.3%) | -$9.60 M(+35.2%) |
| Mar 1997 | - | -$2.40 M(+26.3%) | -$7.10 M(-1.4%) |
| Dec 1996 | -$7.20 M(+41.2%) | -$1.90 M(-29.6%) | -$7.20 M(0.0%) |
| Sep 1996 | - | -$2.70 M(+2600.0%) | -$7.20 M(+26.3%) |
| Jun 1996 | - | -$100.00 K(-96.0%) | -$5.70 M(0.0%) |
| Mar 1996 | - | -$2.50 M(+31.6%) | -$5.70 M(+16.3%) |
| Dec 1995 | -$5.10 M(+4.1%) | -$1.90 M(+58.3%) | -$4.90 M(-2.0%) |
| Sep 1995 | - | -$1.20 M(+1100.0%) | -$5.00 M(+2.0%) |
| Jun 1995 | - | -$100.00 K(-94.1%) | -$4.90 M(-7.5%) |
| Mar 1995 | - | -$1.70 M(-15.0%) | -$5.30 M(+3.9%) |
| Dec 1994 | -$4.90 M(+188.2%) | -$2.00 M(+81.8%) | -$5.10 M(+18.6%) |
| Sep 1994 | - | -$1.10 M(+120.0%) | -$4.30 M(-2.3%) |
| Jun 1994 | - | -$500.00 K(-66.7%) | -$4.40 M(-13.7%) |
| Mar 1994 | - | -$1.50 M(+25.0%) | -$5.10 M(+218.8%) |
| Dec 1993 | -$1.70 M(-5.6%) | -$1.20 M(0.0%) | -$1.60 M(-69.8%) |
| Sep 1993 | - | -$1.20 M(0.0%) | -$5.30 M(+65.6%) |
| Jun 1993 | - | -$1.20 M(-160.0%) | -$3.20 M(+190.9%) |
| Mar 1993 | - | $2.00 M(-140.8%) | -$1.10 M(-50.0%) |
| Dec 1992 | -$1.80 M(+5.9%) | -$4.90 M(-644.4%) | -$2.20 M(+57.1%) |
| Sep 1992 | - | $900.00 K(0.0%) | -$1.40 M(-17.6%) |
| Jun 1992 | - | $900.00 K(0.0%) | -$1.70 M(-15.0%) |
| Mar 1992 | - | $900.00 K(-122.0%) | -$2.00 M(-13.0%) |
| Dec 1991 | -$1.70 M(+41.7%) | -$4.10 M(-783.3%) | -$2.30 M(+76.9%) |
| Sep 1991 | - | $600.00 K(0.0%) | -$1.30 M(-7.1%) |
| Jun 1991 | - | $600.00 K(0.0%) | -$1.40 M(-12.5%) |
| Mar 1991 | - | $600.00 K(-119.4%) | -$1.60 M(-11.1%) |
| Dec 1990 | -$1.20 M | -$3.10 M(-720.0%) | -$1.80 M(-238.5%) |
| Sep 1990 | - | $500.00 K(+25.0%) | $1.30 M(+62.5%) |
| Jun 1990 | - | $400.00 K(0.0%) | $800.00 K(+100.0%) |
| Mar 1990 | - | $400.00 K | $400.00 K |
FAQ
- What is Fresh Tracks Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Fresh Tracks Therapeutics?
- What is Fresh Tracks Therapeutics annual EBITDA year-on-year change?
- What is Fresh Tracks Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Fresh Tracks Therapeutics?
- What is Fresh Tracks Therapeutics quarterly EBITDA year-on-year change?
- What is Fresh Tracks Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Fresh Tracks Therapeutics?
- What is Fresh Tracks Therapeutics TTM EBITDA year-on-year change?
What is Fresh Tracks Therapeutics annual EBITDA?
The current annual EBITDA of FRTX is -$5.65 M
What is the all time high annual EBITDA for Fresh Tracks Therapeutics?
Fresh Tracks Therapeutics all-time high annual EBITDA is -$1.20 M
What is Fresh Tracks Therapeutics annual EBITDA year-on-year change?
Over the past year, FRTX annual EBITDA has changed by +$15.41 M (+73.19%)
What is Fresh Tracks Therapeutics quarterly EBITDA?
The current quarterly EBITDA of FRTX is -$1.23 M
What is the all time high quarterly EBITDA for Fresh Tracks Therapeutics?
Fresh Tracks Therapeutics all-time high quarterly EBITDA is $16.98 M
What is Fresh Tracks Therapeutics quarterly EBITDA year-on-year change?
Over the past year, FRTX quarterly EBITDA has changed by -$3.34 M (-158.06%)
What is Fresh Tracks Therapeutics TTM EBITDA?
The current TTM EBITDA of FRTX is -$5.65 M
What is the all time high TTM EBITDA for Fresh Tracks Therapeutics?
Fresh Tracks Therapeutics all-time high TTM EBITDA is $3.60 M
What is Fresh Tracks Therapeutics TTM EBITDA year-on-year change?
Over the past year, FRTX TTM EBITDA has changed by +$3.29 M (+36.79%)